Plasma biomarker screening could improve accuracy, health equity in Alzheimer’s disease diagnosis – Mayo Clinic News Network

JACKSONVILLE, Fla. — Mayo Clinic researchers have identified a new set of molecular markers in blood plasma. This discovery could lead to the development of improved diagnostic tests for Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia, affecting 6.2 million people in the U.S. The Mayo Clinic study, published in eBioMedicine, is […]

Read the full article here

Related Articles